Acquired Haemophilia A: A Review of What We Know.
Ontology highlight
ABSTRACT: Autoantibodies against plasma coagulation factors could be developed by some individuals inducing severe and sometimes fatal bleedings. This clinical entity is called acquired haemophilia. It should be suspected in subjects with acute abnormal bleedings, without personal or familiar history of congenital bleeding disorders with an unexplained prolonged aPTT. It is rare disease, although its incidence may be underestimated due to the low knowledge about it by many specialists, the frequent use of anticoagulant or antiplatelet therapies in the affected population that can mask the diagnosis and, sometimes, a so withering effect that avoid its confirmation. Mortality ranges between 9% and 33% depending on the series in the first 2 months after diagnosis. This mortality is attributed in up to
SUBMITTER: Mingot-Castellano ME
PROVIDER: S-EPMC9701517 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA